Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by beechguyon Aug 13, 2014 11:42am
254 Views
Post# 22836774

RE:RE:Why a buyout offer is iminent.

RE:RE:Why a buyout offer is iminent. Lorneg/ SWNE/ Nonuknuk whichever one you are using today... The vaccine plant may be worth much less than 60mm, however that is what it costs to build it. What is ends up being worth to a buyer has yet to be decided. My point is for a potential suitor with a vaccine business is, it is a nice value added bonus. As far as your valuation on approval. Give me a break. FDA approval would value us easily north of 500mm. Even at the lowest revenue estimates of 200mm at a 5 multiple, that's a billion (or $7 /share). Good to see you and your many handles back to bashing. Most on this board know that can only be a good sign! beech
<< Previous
Bullboard Posts
Next >>